Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0002139479-26-000004

Options or other derivatives

  • Chief Commercial Officer acquired 285,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Sims Mark E. · Chief Commercial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-07-06 Grant or award : show line 1 in the form Stock Option (Right to Buy) +285,000 285,000 D
Loading xslF345X06/ownership.xml…